荣昌生物(09995.HK)今日盘中大涨5.12%,引发市场关注。分析人士认为,这主要受到该公司前三季度业绩表现利好的影响。
荣昌生物公布的2024年前三季度财报显示,公司全年前三季度实现营业收入12.09亿元人民币,同比大增57.1%。虽然前三季度仍然处于亏损状态,但亏损额较上年同期有所收窄,为10.71亿元,同比下降3.96%。
值得关注的是,单季度数据反映出荣昌生物的经营状况出现明显改善。2024年第三季度,公司实现营业收入4.67亿元,同比增长34.6%;单季度亏损2.91亿元,同比收窄11.08%。财报数据透露出公司销售收入增长、亏损幅度收窄的良好势头。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.